Immix Biopharma IMMX Institutional Ownership

Updated Oct 10, 2026

Immix Biopharma, Inc. (NASDAQ:IMMX) counted 110 institutional investors among its 13F-reported shareholders for the quarter ended June 30, 2026.

• Together they owned 78.59% of the outstanding stock in Q2 2026, up from 48.90% a quarter earlier.
• Total shares held in Immix Biopharma rose 107.64% versus Q1 2026, while the number of holders rose 400.00% versus Q2 2025.
• Of the 110 holders of IMMX in Q2 2026, 81 added to their positions, 13 reduced their stakes and 16 left their positions unchanged.
• Altogether, institutional holders owned 56.22Mn IMMX shares at the end of Q2 2026, up 29.14Mn from the prior quarter and up 54.08Mn from a year earlier.
• As of June 30, 2026, Jupiter Topco LLC held the largest stake in Immix Biopharma with 9.78Mn shares, or 13.68% of shares outstanding.
• Holders that added the most shares of Immix Biopharma in Q2 2026 were State Street Corp (+2.81Mn shares), BlackRock, Inc. (+2.52Mn shares), UBS Group AG (+1.86Mn shares), Eventide Asset Management, LLC (+1.34Mn shares) and T. Rowe Price Associates Inc (+1.32Mn shares).
• The biggest cuts to IMMX positions during Q2 2026 came from Susquehanna International Group, LLP (-432.66K shares), Logos Global Management LP (-225K shares), Blue Owl Capital Holdings LP (-110K shares), SEI Investments Co (-79.79K shares) and Qube Research & Technologies Ltd (-45.71K shares).
• Business Quant data shows the 10 biggest positions in Immix Biopharma as of Q2 2026 were held by Jupiter Topco LLC (9.78Mn shares), Saturn V Capital Management LP (4.66Mn shares), Eventide Asset Management, LLC (3.89Mn shares), State Street Corp (3Mn shares), BlackRock, Inc. (2.99Mn shares), Deep Track Capital, LP (2.77Mn shares), Vanguard Capital Management LLC (2.51Mn shares), Opaleye Management Inc. (2.35Mn shares), Millennium Management LLC (2.07Mn shares) and UBS Group AG (1.94Mn shares).